Tempus AI and Pathos AI Sign Neurology Data Deal Worth Up to $55 Million

Tempus will seek to license Pathos 500,000 de-identified records over five years; Bristol Myers Squibb will get Foundry access and three-year exclusive rights to support its neuroscience development programs.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.